Related Experiment Video

Updated: Jun 27, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

A review of trials evaluating nonstatin lipid-lowering therapies

Benjamin J Ansell1

  • 1Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. bansell@mednet.ucla.edu

Current Atherosclerosis Reports
|December 17, 2008
PubMed

Insights

Non-statin lipid-lowering drugs added to statin therapy show limited cardiovascular benefits. Some therapies, like torcetrapib, increased mortality, while others like ezetimibe offered no additional advantage over statins alone.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Clinical Trials

Background:

  • Statin therapy is a cornerstone for managing cardiovascular risk.
  • Residual cardiovascular risk persists despite optimal statin treatment.
  • Non-statin lipid-lowering therapies are explored to further reduce this risk.

Purpose of the Study:

  • To evaluate the efficacy and safety of non-statin lipid-lowering therapies when added to statin monotherapy.
  • To assess the impact of these combination therapies on cardiovascular events and mortality.
  • To review current evidence and ongoing trials regarding non-statin add-on therapies.

Main Methods:

  • Review of recently reported clinical trial data.
  • Analysis of outcomes from combination therapies including -torcetrapib, ezetimibe, and niacin/laropiprant with statins.
  • Examination of effects on high-density lipoprotein cholesterol, atherosclerosis progression, and cardiovascular events.

Main Results:

  • -Torcetrapib addition to statins increased overall mortality in coronary patients.
  • Ezetimibe combined with statins did not significantly reduce carotid atherosclerosis or slow aortic stenosis.
  • Evidence for improved cardiovascular event reduction with ezetimibe/statin combination over statin monotherapy is lacking.

Conclusions:

  • Current evidence casts doubt on the effectiveness of certain non-statin lipid-lowering therapies as add-ons to statins.
  • The addition of some non-statin agents may increase risks, such as elevated mortality.
  • Ongoing clinical trials are crucial to definitively establish the role and safety of these combination therapies.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...